Home Watchlists Portfolios Indices Forex Futures Crypto Comparisons Alerts Screeners Scans Settings

Aerie Pharmaceuticals (NASDAQ:AERI) Price Target Cut to $41.00 by Analysts at HC Wainwright



  • Source: Polson News - - Read: 0

    Summary:

     

    Aerie Pharmaceuticals (NASDAQ:AERI) had its target price reduced by HC Wainwright from $55.00 to $41.00 in a research report released on Thursday morning, The Fly reports. HC Wainwright currently has a buy rating on the stock.

    A number of other brokerages have also issued reports on AERI. Needham & Company LLC reissued a buy rating and set a $54.00 target price on shares of Aerie Pharmaceuticals in a research note on Friday, October 25th. BidaskClub raised shares of Aerie Pharmaceuticals from a strong sell rating to a sell rating in a research note on Wednesday, October 30th. JMP Securities lowered their target price on shares of Aerie Pharmaceuticals from $58.00 to $52.00 and set a market outperform rating for the company in a research note on Thursday, August 8th. Mizuho reissued ...

     

     

    Read Full News: https://polsonnews.com/aerie-pharmaceuticals-nasdaqaeri-price-target-cut-to-41-00-by-analysts-at-hc-wainwright/


Log in to reply